Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

Macro-autophagy is associated with drug resistance in various cancers and can function as an adaptive response to maintain cell survival under metabolic stresses, including androgen deprivation. Androgen deprivation or treatment with androgen receptor (AR) signaling inhibitor (ARSI), Enzalutamide (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, H G, Yang, J C, Kung, H-J, Shi, X-B, Tilki, D, Lara, P N, DeVere White, R W, Gao, A C, Evans, C P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155805/
https://www.ncbi.nlm.nih.gov/pubmed/24662833
http://dx.doi.org/10.1038/onc.2014.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155805/
https://www.ncbi.nlm.nih.gov/pubmed/24662833
http://dx.doi.org/10.1038/onc.2014.25

Ejemplares similares